References
- Gianfaldoni S, Tchernev G, Wollina U, et al. Vitiligo in children: a better understanding of the disease. Open Access Maced J Med Sci. 2018;6(1):181–184.
- Nicolaidou E, Mastraftsi S, Tzanetakou V, et al. Childhood vitiligo. Am J Clin Dermatol. 2019;20(4):515–526.
- Van Driessche F, Silverberg N. Current management of pediatric vitiligo. Paediatr Drugs. 2015;17(4):303–313.
- Ezzedine K, Silverberg N. A practical approach to the diagnosis and treatment of vitiligo in children. Pediatrics. 2016;138(1):e20154126.
- Lei TC, Xu AE, Gao TW, et al. Consensus on the diagnosis and treatment of vitiligo in China. Int J Dermatol Venereol. 2021;4(1):10–15.
- Dong Y, Yang Q, Guo B, et al. The effects of tacrolimus plus phototherapy in the treatment of vitiligo: a meta-analysis. Arch Dermatol Res. 2021;313(6):461–471.
- Rath N, Kar HK, Sabhnani S. An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad/narrow band UVB phototherapy in progressive vitiligo. Indian J Dermatol Venereol Leprol. 2008;74(4):357–360.
- Tay EY, Chong CLV, Chong WJJP, et al. Treatment outcomes of vitiligo in Asian children. Pediatr Dermatol. 2018;35(2):265–267.
- Taieb A, Alomar A, Böhm M, et al. Guidelines for the management of vitiligo: the European dermatology forum consensus. Br J Dermatol. 2013;168(1):5–19.
- Njoo MD, Das PK, Bos JD, et al. Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135(4):407–413.
- Mohammad TF, Al-Jamal M, Hamzavi IH, et al. The vitiligo working group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo. J Am Acad Dermatol. 2017;76(5):879–888.
- Hum M, Kalia S, Gniadecki R. Prescribing home narrowband UVB phototherapy: a review of current approaches. J Cutan Med Surg. 2019;23(1):91–96.
- Kim SM, Lee HS, Hann SK. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Int J Dermatol. 1999;38(7):546–550.
- Majid I, Masood Q, Hassan I, et al. Childhood vitiligo: response to methylprednisolone oral minipulse therapy and topical fluticasone combination. Indian J Dermatol. 2009;54(2):124–127.
- Cavalié M, Ezzedine K, Fontas E, et al. Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol. 2015;135(4):970–974.
- Khanna U, Khandpur S. What is new in narrow-band ultraviolet-B therapy for vitiligo? Indian Dermatol Online J. 2019;10(3):234–243.
- Karagaiah P, Valle Y, Sigova J, et al. Emerging drugs for the treatment of vitiligo. Expert Opin Emerg Drugs. 2020;25(1):7–24.
- Park JH, Park SW, Lee DY, et al. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. Photodermatol Photoimmunol Photomed. 2013;29(2):103–105.
- Radakovic-Fijan S, Fürnsinn-Friedl AM, Hönigsmann H, et al. Oral dexamethasone pulse treatment for vitiligo. J Am Acad Dermatol. 2001;44(5):814–817.
- Boniface K, Seneschal J. Vitiligo as a skin memory disease: the need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells. Exp Dermatol. 2019;28(6):656–661.
- Lin Z, Tian Y, Bai B, et al. Comprehensive survey of vitiligo patients in the northeast of China using a predesigned questionnaire. J Dermatol. 2018;45(1):39–45.
- Majid I, Imran S. Excimer light therapy in childhood segmental vitiligo: early treatment gives better results. Dermatol Ther. 2020;33:e13408.
- Majid I, Imran S. Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: a 12-month follow-up study. Indian J Dermatol. 2013;58(2):113–116.
- Kanwar AJ, Mahajan R, Parsad D. Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. J Cutan Med Surg. 2013;17(4):259–268.
- Bishnoi A, Parsad D. Clinical and molecular aspects of vitiligo treatments. IJMS. 2018;19(5):1509.